Chief Business Officer · NEUROONE MEDICAL TECHNOLOGIES Corp · Common Stock
Side
BUY
Value
$67K
Shares
33.3K
Price
$2.01
Executed
Aug 27, 2026
Disclosed
Sep 8, 2026
Disclosure timeline12 days from execution to publication · legal deadline 2 business days
Aug 27 executedSep 8, 2026 disclosed
NMTC · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 8 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Wambeke David J. filed this Form 4 reporting a open-market purchase of NMTC on Aug 27, 2026. It became public on Sep 8, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Business Officer
Wambeke David J.cik:0001971798
Issuer
NEUROONE MEDICAL TECHNOLOGIES Corpcik:0001500198
Revision history · 0
No field has changed since this record was first ingested.
